Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Myriad Genetics
ISIN US62855J1043
|WKN 897518
Market cap (in EUR)
536 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Advertisement
Capital at risk. Execution-only service.
Overview
Description
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
Healthcare Healthcare Equipment United States
Financials
Key metrics
| Market capitalisation, EUR | 536 m |
| EPS, EUR | -3.93 |
| P/B ratio | 1.7 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 774 m |
| Net income, EUR | -118 m |
| Profit margin | -15.20% |
What ETF is Myriad Genetics in?
There are 23 ETFs which contain Myriad Genetics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Myriad Genetics is the Global X Genomics & Biotechnology UCITS ETF.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.